Skip to content
November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
A Global Partnership at a Crossroads: Analyzing the Strained Relationship Between the U.S. and the WHO a-global-partnership-at-a-crossroads-analyzing-the-strained-relationship-between-the-u-s-and-the-who
  • Global Breast Cancer Awareness

A Global Partnership at a Crossroads: Analyzing the Strained Relationship Between the U.S. and the WHO

Sagoh October 8, 2026
In the complex landscape of international diplomacy and global public health, few relationships have been as foundational—or...
Read More Read more about A Global Partnership at a Crossroads: Analyzing the Strained Relationship Between the U.S. and the WHO
Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series navigating-the-post-treatment-journey-breast-cancer-canadas-october-education-series-3
  • Global Breast Cancer Awareness

Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

Iffa Jayyana October 8, 2026
As the landscape of breast cancer care continues to evolve, the focus for patients is shifting from...
Read More Read more about Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series
Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Nana Muazin October 8, 2026
Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...
Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape arrivents-firmonertinib-falls-short-in-key-nsclc-trial-sending-stock-plummeting-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape

Basiran October 8, 2026
Disappointing Phase III results for ArriVent BioPharma’s lead candidate, firmonertinib, in the treatment of non-small cell lung...
Read More Read more about ArriVent’s Firmonertinib Falls Short in Key NSCLC Trial, Sending Stock Plummeting Amidst Competitive Landscape
Navigating the Intersection of GLP-1 Medications and Breast Cancer: An Evolving Landscape navigating-the-intersection-of-glp-1-medications-and-breast-cancer-an-evolving-landscape
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: An Evolving Landscape

Nana Muazin October 8, 2026
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, widely...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: An Evolving Landscape
The Architect of Precision Oncology: How Tameron Harvell is Bridging the Gap Between Genomic Science and Clinical Care the-architect-of-precision-oncology-how-tameron-harvell-is-bridging-the-gap-between-genomic-science-and-clinical-care
  • Patient Advocacy and Support

The Architect of Precision Oncology: How Tameron Harvell is Bridging the Gap Between Genomic Science and Clinical Care

Ammar Sabilarrohman October 8, 2026
HUNTSVILLE, AL — In the rapidly shifting landscape of modern oncology, the distance between a high-tech laboratory...
Read More Read more about The Architect of Precision Oncology: How Tameron Harvell is Bridging the Gap Between Genomic Science and Clinical Care
Headline: Beyond the Pink Ribbon: How the Breast Cancer Research Foundation Transformed Grand Central Into a Global Hub for Scientific Progress headline-beyond-the-pink-ribbon-how-the-breast-cancer-research-foundation-transformed-grand-central-into-a-global-hub-for-scientific-progress
  • Patient Advocacy and Support

Headline: Beyond the Pink Ribbon: How the Breast Cancer Research Foundation Transformed Grand Central Into a Global Hub for Scientific Progress

Asep Darmawan October 8, 2026
NEW YORK CITY — On a Tuesday that bridged the gap between the morning commute and a...
Read More Read more about Headline: Beyond the Pink Ribbon: How the Breast Cancer Research Foundation Transformed Grand Central Into a Global Hub for Scientific Progress
Closing the Gaps: Canadians Calling For More closing-the-gaps-canadians-calling-for-more
  • Patient Advocacy and Support

Closing the Gaps: Canadians Calling For More

Ali Ikhwan October 8, 2026
OTTAWA – As the landscape of oncology shifts toward increasingly personalized medicine, a comprehensive new national survey...
Read More Read more about Closing the Gaps: Canadians Calling For More
Global Health Solidarity: Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan global-health-solidarity-dr-tedros-adhanom-ghebreyesus-concludes-landmark-visit-to-jordan
  • Breast Cancer Prevention and Lifestyle

Global Health Solidarity: Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan

Ali Ikhwan October 8, 2026
AMMAN – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded the...
Read More Read more about Global Health Solidarity: Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan
The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives the-twilight-of-a-crispr-pioneer-caribou-biosciences-seeks-strategic-alternatives
  • Treatment Innovations

The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives

Nana Wu October 8, 2026
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company anchored by the prestige...
Read More Read more about The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives

Posts pagination

Previous 1 … 164 165 166 167 168 169 170 … 873 Next

Recent Posts

  • Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer
  • Pregnancy complication indicator for risk of disease
  • Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery
  • A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients
  • The Missing Link: Why Your Mid-Back Strength Is the Secret to Longevity

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unraveling-the-paradox-breakthrough-study-redefines-immunotherapy-for-colorectal-cancer
  • Medical Research and Clinical Trials

Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer

Reynand Wu November 8, 2026
pregnancy-complication-indicator-for-risk-of-disease
  • Medical Research and Clinical Trials

Pregnancy complication indicator for risk of disease

Siti Muinah November 8, 2026
beyond-the-spaghetti-talus-bios-structure-free-revolution-in-drug-discovery
  • Treatment Innovations

Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery

Reynand Wu November 8, 2026
a-new-dawn-in-genomic-medicine-casgevy-now-available-on-the-nhs-for-blood-disorder-patients
  • Genomics and Precision Medicine

A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients

Ammar Sabilarrohman November 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.